Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Exocrine Pancreatic Insufficiency : An Overview


Affiliations
1 General Medicine, TNMC & Nair Hospital, Mumbai, India
     

   Subscribe/Renew Journal


Exocrine Pancreatic Insufficiency (EPI) is identified by the insufficiency of exocrine pancreatic enzymes resulting in malabsorption. Patients with mild EPI maybe asymptomatic or have mild abdominal discomfort and bloating while advanced EPI results in steatorrhea and weight loss. The causes can be divided into pancreatic and extra-pancreatic origin. Pancreatic causes include chronic pancreatitis, cystic fibrosis, pancreatic tumors, and pancreatic resection. Extra-pancreatic causes include diabetes, IBD, celiac disease, etc.There are various direct and indirect tests available to diagnose EPI, with indirect ones such as the concentration of fecal elastase beingmost commonly used. However, the gold standard test for diagnosis is a72-hour fecal fat test.Treatment for pancreatic exocrine insufficiency includes lifestyle modifications, dietary consultation, and a structured assessment of nutritional status. The mainstay remains pancreatic enzyme replacement therapy, which is administered in the form of enteric-coated minimicrospheres during meals.

Keywords

Chronic Pancreatitis, Malabsorption, Fecal Elastase, Pancreatic Enzyme Replacement Therapy.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Capurso G, Traini M, Piciucchi M, Signoretti M and Arcidiacon P. Exocrine pancreatic insufficiency: prevalence, diagnosis, and management. Clinical and Experimental Gastroenterology. 2019;12:129-139.
  • Domínguez-Muñoz J. Pancreatic exocrine insufficiency: Diagnosis and treatment. Journal of Gastroenterology and Hepatology. 2011;26:12-16.
  • Struyvenberg M, Martin C, Freedman S. Practical guide to exocrine pancreatic insufficiency – Breaking the myths. BMC Med. 2017;15:29.
  • de la Iglesia-Garcia D, Vallejo-Senra N, Iglesias-Garcia J, López-López A, Nieto L, Domínguez-Muñoz J. Increased Risk of Mortality Associated with Pancreatic Exocrine Insufficiency in Patients With Chronic Pancreatitis. Journal of Clinical Gastroenterology. 2018;52(8):63-72.
  • Stigliano S, Waldthaler A, Martinez-Moneo E, et al. Vitamins D and K as factors associated with osteopathy in chronic pancreatitis: a prospective multicentre study (P-BONE study). Clin Transl Gastroenterol. 2018;9(10):197.
  • Martínez-Moneo E, Stigliano S, Hedström A, et al. Deficiency of fat-soluble vitamins in chronic pancreatitis: a systematic review and meta-analysis. Pancreatology. 2016;16(6):988–994.
  • Löhr JM, Dominguez-Munoz E, Rosendahl J, et al. United European gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis. United European Gastroenterol J. 2017;5(2):153–199.
  • Machicado JD, Chari ST, Timmons L, Tang G, Yadav D. A population-based evaluation of the natural history of chronic pancreatitis. Pancreatology. 2018;18(1):39–45.
  • Ooi CY, Castellani C, Keenan K, et al. Inconclusive diagnosis of cystic fibrosis after newborn screening. Pediatrics. 2015;135(6):1377–1385.
  • Hardt PD, Ewald N. Exocrine pancreatic insufficiency in diabetes mellitus: A complication of diabetic neuropathy or a different type of diabetes? Experimental Diabetes Research. 2011;2011:1-7.
  • Lindkvist B. Diagnosis and treatment of pancreatic exocrine insufficiency. World J Gastroenterol. 2013;19:7258-7266.
  • Keller J, Layer P. Human pancreatic exocrine response to nutrients in health and disease. Gut. 2005;54(6):1-28.
  • Seiler CM, Izbicki J, Varga-Szabó L, et al. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension. Aliment Pharmacol Ther. 2013;37(7):691–702.
  • Gullo L, Ventrucci M, Tomassetti P, Migliori M, Pezzilli R. Fecal elastase 1 determination in chronic pancreatitis. Dig Dis Sci. 1999;44(2):290–290.
  • Lieb JG, Draganov PV. Pancreatic function testing: here to stay for the 21st century. World J Gastroenterol.2018;14(20):3149–3158.
  • Beharry S, Ellis L, Corey M, Marcon M, Durie P. How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? J Pediatr. 2002;141:84–90.
  • Couper RT, Corey M, Durie PR, Forstner GG, Moore DJ. Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic-sufficient patients with cystic fibrosis. J Pediatr. 1995;127(3):408–413.
  • Cappeliez O, Delhaye M, Devière J, et al. Chronic pancreatitis: evaluation of pancreatic exocrine function with MR pancreatography after secretin stimulation. Radiology. 2000;215(2):358–364.
  • Nikfarjam M, Wilson JS, Smith RC; Australasian Pancreatic Club Pancreatic Enzyme Replacement Therapy Guidelines Working Group. Diagnosis and management of pancreatic exocrine insufficiency. Med J Aust. 2017;207(4):161-165.
  • Borowitz DS, Grand RJ, Durie PR. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. J Pediatr. 1995;127:681–4.

Abstract Views: 24

PDF Views: 0




  • Exocrine Pancreatic Insufficiency : An Overview

Abstract Views: 24  |  PDF Views: 0

Authors

Ashni Dharia
General Medicine, TNMC & Nair Hospital, Mumbai, India
Charmi Bhanushali
General Medicine, TNMC & Nair Hospital, Mumbai, India

Abstract


Exocrine Pancreatic Insufficiency (EPI) is identified by the insufficiency of exocrine pancreatic enzymes resulting in malabsorption. Patients with mild EPI maybe asymptomatic or have mild abdominal discomfort and bloating while advanced EPI results in steatorrhea and weight loss. The causes can be divided into pancreatic and extra-pancreatic origin. Pancreatic causes include chronic pancreatitis, cystic fibrosis, pancreatic tumors, and pancreatic resection. Extra-pancreatic causes include diabetes, IBD, celiac disease, etc.There are various direct and indirect tests available to diagnose EPI, with indirect ones such as the concentration of fecal elastase beingmost commonly used. However, the gold standard test for diagnosis is a72-hour fecal fat test.Treatment for pancreatic exocrine insufficiency includes lifestyle modifications, dietary consultation, and a structured assessment of nutritional status. The mainstay remains pancreatic enzyme replacement therapy, which is administered in the form of enteric-coated minimicrospheres during meals.

Keywords


Chronic Pancreatitis, Malabsorption, Fecal Elastase, Pancreatic Enzyme Replacement Therapy.

References